The Vienna General Hospital, usually abbreviated to AKH, is the general hospital of the city of Vienna, Austria. It is also the city's university hospital, and the site of the Medical University of Vienna. It is Europe's fifth largest hospital, both by number of employees and bed capacity.

There are 2,200 beds in Vienna General Hospital.

During the past decade, Vienna General Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 3 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vienna General Hospital" #1 sponsor was "Medical University of Vienna" with 21 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Actelion" with 3 trials sponsored, "Mallinckrodt" with 3 trials sponsored and "Vienna General Hospital" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vienna General Hospital" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Surgebright Gmbh" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Barmherzige Brüder Eisenstadt" with 1 trials as a collaborator and "British Medical Research Council" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Vienna General Hospital" are "Coronary Artery Disease" (3 trials), "Pulmonary Hypertension" (3 trials), "Age Related Cataracts" (2 trials), "Astigmatism" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Vienna General Hospital" in a lesser frequency.

Most popular intervention types in "Vienna General Hospital" are "Drug" (34 trials), "Other" (13 trials), "Device" (12 trials), "Procedure" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "bosentan" (4 trials), "Extracorporeal Photopheresis" (3 trials), "Bevacizumab" (2 trials), "Methoxsalen" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vienna General Hospital" are 61 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Vienna General Hospital". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Vienna General Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vienna General Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".